Skip to main content

Table 4 Percentage Reduction in Study Variables

From: Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study

Study Variables Liraglutide, N = 30 Dulaglutide, N = 30 p
Percent Change in Body weight
Mean ± SEM
−5.83 ± 0.87 −4.2 ± 0.46 0.103
Percent Change in BMI, Mean ± SEM −2.27 ± 0.33 1.53 ± 0.20 0.061
Percent Change in SBP, Mean ± SEM −10.23 ± 2.36 −3.43 ± 2.98 0.079
Percent Change in DBP, Mean ± SEM −2.8 ± 1.85 −2.3 ± 1.79 0.847
Percent Change in FPG, Mean ± SEM −44.2 ± 8.05 −41.87 ± 12.72 0.877
Percent Change in HbA1c, Mean ± SEM − 1.55 ± 0.22 −1.02 ± 0.22 0.091